Package 71335-0877-2

{"route": ["ORAL"], "spl_id": "7a02762a-5d8d-4874-9fc2-b4d74458eee7", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993687"], "spl_set_id": ["c1fa6fce-272b-4497-a958-177f0bafdfc7"], "manufacturer_name": ["Bryant Ranch Prepack"]}, "finished": true, "packaging": [{"sample": false, "description": "60 TABLET in 1 BOTTLE (71335-0877-1)", "package_ndc": "71335-0877-1", "marketing_start_date": "20180907"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (71335-0877-2)", "package_ndc": "71335-0877-2", "marketing_start_date": "20180621"}, {"sample": false, "description": "100 TABLET in 1 BOTTLE (71335-0877-3)", "package_ndc": "71335-0877-3", "marketing_start_date": "20211227"}, {"sample": false, "description": "90 TABLET in 1 BOTTLE (71335-0877-4)", "package_ndc": "71335-0877-4", "marketing_start_date": "20180913"}, {"sample": false, "description": "120 TABLET in 1 BOTTLE (71335-0877-5)", "package_ndc": "71335-0877-5", "marketing_start_date": "20211227"}, {"sample": false, "description": "15 TABLET in 1 BOTTLE (71335-0877-6)", "package_ndc": "71335-0877-6", "marketing_start_date": "20211227"}, {"sample": false, "description": "21 TABLET in 1 BOTTLE (71335-0877-7)", "package_ndc": "71335-0877-7", "marketing_start_date": "20211227"}], "brand_name": "bupropion Hydrochloride", "product_id": "71335-0877_7a02762a-5d8d-4874-9fc2-b4d74458eee7", "dosage_form": "TABLET", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "71335-0877", "generic_name": "bupropion Hydrochloride", "labeler_name": "Bryant Ranch Prepack", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "bupropion Hydrochloride", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "100 mg/1"}], "application_number": "ANDA207389", "marketing_category": "ANDA", "marketing_start_date": "20180526", "listing_expiration_date": "20261231"}